FDA adds two behavioral health firms to TEMPO pilot, including an AI voice agent for talk therapy
The FDA has added two behavioral health companies to its TEMPO pilot program, including one offering talk therapy through an AI voice agent. MedPath Trial reported the news.
Sources
- FDA Adds Two Behavioral Health Firms to TEMPO Pilot, Including an AI Voice Agent for Talk Therapy - MedPath Trialtrial.medpath.com · Aug 24, 2026
- FDA selects Limbic for TEMPO pilot to test voice AI therapy on... | Pivot Newspivotnews.ai · Aug 27, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The facts come from the linked article.